MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 49 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,900 | -24.6% | 23,570 | +7.9% | 0.00% | – |
| Q2 2023 | $149,673 | +35.3% | 21,850 | +53.9% | 0.00% | – |
| Q1 2023 | $110,618 | +17.2% | 14,200 | +14.5% | 0.00% | – |
| Q4 2022 | $94,364 | -91.7% | 12,400 | -84.7% | 0.00% | – |
| Q1 2022 | $1,140,000 | -38.1% | 81,302 | -9.8% | 0.00% | -100.0% |
| Q4 2021 | $1,841,000 | -2.1% | 90,169 | +6.8% | 0.00% | 0.0% |
| Q3 2021 | $1,881,000 | -40.4% | 84,447 | -39.3% | 0.00% | 0.0% |
| Q2 2021 | $3,157,000 | – | 139,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $33,422,000 | 5.35% |
| Cormorant Asset Management, LP | 3,193,973 | $69,550,000 | 2.36% |
| NEA Management Company, LLC | 7,703,205 | $174,863,000 | 2.28% |
| Octagon Capital Advisors LP | 238,045 | $5,404,000 | 1.12% |
| Avoro Capital Advisors LLC | 3,311,434 | $62,153,000 | 1.08% |
| Alphabet Inc. | 1,464,015 | $33,233,000 | 0.68% |
| Logos Global Management LP | 300,000 | $6,810,000 | 0.57% |
| Casdin Capital, LLC | 960,883 | $21,812,000 | 0.55% |
| RTW INVESTMENTS, LP | 1,214,572 | $25,228,000 | 0.38% |
| Monashee Investment Management LLC | 120,000 | $2,724,000 | 0.33% |